Postoperative health-care utilization in Crohn's disease: The impact of specialist care

American Journal of Gastroenterology

Volumn 107, Issue 10, 2012, Pages 1522-1529

  Nguyen, Geoffrey C ^a,b,c   Saibil, Fred ^a   Hillary Steinhart, A ^a   Li, Qi ^b   Tinmouth, Jill M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; CROHN DISEASE; EARLY POSTOPERATIVE GASTROINTESTINAL CARE; EMERGENCY WARD; ENDOSCOPY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOLOGICAL PROCEDURES; RURAL AREA;

ADULT; AGED; COHORT STUDIES; COMORBIDITY; CROHN DISEASE; EMERGENCY SERVICE, HOSPITAL; FEMALE; GASTROENTEROLOGY; HEALTH RESOURCES; HUMANS; INCOME; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OFFICE VISITS; ONTARIO; PATIENT ADMISSION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84867096111     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.235     Document Type: Article

References (26)

1. Longobardi T, Bernstein CN. Health care resource utilization in infl ammatory bowel disease. Clin Gastroenterol Hepatol 2006; 4: 731-43.
2. Longobardi T, Jacobs P, Bernstein CN. Utilization of health care resources by individuals with infl ammatory bowel disease in the United States: a profi le of time since diagnosis. Am J Gastroenterol 2004; 99: 650-5.
3. Solberg IC, Vatn MH, Hoie O et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 2007; 5: 1430-8.
4. Nguyen GC, Nugent Z, Shaw S et al. Outcomes of patients with Crohn's disease improved from 1988 to 2008 and were associated with increased specialist care. Gastroenterology 2011; 141: 90-7.
5. Lichtenstein GR, Yan S, Bala M et al. Infl iximab maintenancetreatment reduces hospitalizations, surgeries, and procedures in fi stulizing Crohn's disease. Gastroenterology 2005; 128: 862-9.
6. Rubenstein JH, Chong RY, Cohen RD. Infl iximab decreases resource use among patients with Crohn's disease. J Clin Gastroenterol 2002; 35: 151-6.
7. Feagan BG, Panaccione R, Sandborn WJ et al. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. Gastroenterology 2008; 135: 1493-9.
8. Nugent Z, Blanchard JF, Bernstein CN. A population-based study of health-care resource use among infl iximab users. Am J Gastroenterol 2010; 105: 2009-16.
9. Rutgeerts P, Geboes K, Vantrappen G et al. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis aft er curative surgery. Gut 1984; 25: 665-72.
10. Gordon M, Naidoo K, Thomas AG et al. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database Syst Rev 2011; (1): CD008414.
11. Doherty G, Bennett G, Patil S et al. Interventions for prevention of postoperative recurrence of Crohn's disease. Cochrane Database Syst Rev 2009; (4): CD006873.
12. Peyrin-Biroulet L, Deltenre P, Ardizzone S et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am J Gastroenterol 2009; 104: 2089-96.
13. Papay P, Reinisch W, Ho E et al. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease aft er fi rst intestinal surgery. Am J Gastroenterol 2010; 105: 1158-64.
14. Hanauer SB, Korelitz BI, Rutgeerts P et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004; 127: 723-9.
15. Regueiro M, Schraut W, Baidoo L et al. Infl iximab prevents Crohn's disease recurrence aft er ileal resection. Gastroenterology 2009; 136: 441-50.
16. Rutgeerts P, Hiele M, Geboes K et al. Controlled trial of metronidazoletreatment for prevention of Crohn's recurrence aft er ileal resection. Gastroenterology 1995; 108: 1617-21.
17. Rutgeerts P, van AG, Vermeire S et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005; 128: 856-61.
18. Bernstein CN, Blanchard JF, Rawsthorne P et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a populationbased study. Am J Epidemiol 1999; 149: 916-24.
19. Statistics Canada: Statistics Canada Postal Code Conversion File September 2002 Postal Codes Reference Guide Catalogue 92F0153GIE. Ministry of Industry: Ottawa, 2002.
20. Starfi eld B, Lemke KW, Herbert R et al. Comorbidity and the use of primary care and specialist care in the elderly. Ann Fam Med 2005; 3: 215-22.
21. Reid RJ, Roos NP, MacWilliam L et al. Assessing population health care need using a claims-based ACG morbidity measure: a validation analysis in the Province of Manitoba. Health Serv Res 2002; 37: 1345-64.
22. Juurlink D, Preyra C, Croxford R et al. Canadian Institute for Health Information Discharge Abstract Database: A Validation Study. Institute for Clinical Evaluative Sciences: Toronto, 2006.
23. Rutgeerts P, Geboes K, Vantrappen G et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99: 956-63.
24. Stukel TA, Fisher ES, Wennberg DE et al. Analysis of observational studies in the presence of treatment selection bias: eff ects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007; 297: 278-85.
25. McClellan M, McNeil BJ, Newhouse JP. Does more intensivetreatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA 1994; 272: 859-66.
26. Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health 1998; 19: 17-34.